{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T13:28:15Z","timestamp":1770816495728,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.ijantimicag.2013.10.012","type":"journal-article","created":{"date-parts":[[2013,11,15]],"date-time":"2013-11-15T11:15:51Z","timestamp":1384514151000},"page":"165-169","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort"],"prefix":"10.1016","volume":"43","author":[{"given":"Herbert","family":"Spapen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerrold","family":"Spapen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio S.","family":"Taccone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wouter","family":"Meersseman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Rello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Dimopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre-Emmanuel","family":"Charles","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratna","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcos","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claude","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Vogelaers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stijn I.","family":"Blot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0005","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2165\/00003495-200767110-00004","article-title":"Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients","volume":"67","author":"Maschmeyer","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1164\/rccm.200401-093OC","article-title":"Invasive aspergillosis in critically ill patients without malignancy","volume":"170","author":"Meersseman","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0015","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1179\/acb.2004.037","article-title":"Invasive aspergillosis in critically ill patients: analysis of risk factors for acquisition and mortality","volume":"59","author":"Vandewoude","year":"2004","journal-title":"Acta Clin Belg"},{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2013.10.012_bib0020","first-page":"S37","article-title":"Aspergilloma of the brain: an overview","volume":"51","author":"Nadkarni","year":"2005","journal-title":"J Postgrad Med"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.201111-1978OC","article-title":"A clinical algorithm to diagnose invasive pulmonary aspergillosis in critically ill patients","volume":"186","author":"Blot","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0030","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1086\/588660","volume":"46","author":"De Pauw","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0035","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1186\/cc4823","article-title":"Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients","volume":"10","author":"Vandewoude","year":"2006","journal-title":"Crit Care"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0040","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1513\/pats.200906-050AL","article-title":"Aspergillus infections in the critically ill","volume":"7","author":"Dutkiewicz","year":"2010","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0045","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00005792-200007000-00006","article-title":"Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group","volume":"79","author":"Patterson","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0050","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/0002-9149(80)90659-1","article-title":"Fungal infections of the heart: analysis of 51 autopsy cases","volume":"45","author":"Walsh","year":"1980","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0055","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1128\/JCM.37.4.1186-1189.1999","article-title":"Aspergillus meningitis: diagnosis by non-culture-based microbiological methods and management","volume":"37","author":"Verweij","year":"1999","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0060","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jinf.2012.11.003","article-title":"Aspergillus meningitis: a rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases","volume":"66","author":"Antinori","year":"2013","journal-title":"J Infect"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0065","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1076-6332(03)80166-6","article-title":"Imaging findings in intracranial aspergillosis","volume":"9","author":"Yamada","year":"2002","journal-title":"Acad Radiol"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0070","first-page":"1597","article-title":"Disseminated aspergillosis involving the brain: distribution and imaging characteristics","volume":"20","author":"DeLone","year":"1999","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0075","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1086\/315643","article-title":"Comparative efficacy and distribution of lipid formulations of amphotericin B in experimental Candida albicans infection of the central nervous system","volume":"182","author":"Groll","year":"2000","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0080","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1517\/17425255.3.4.573","article-title":"CNS pharmacokinetics of antifungal agents","volume":"3","author":"Kethireddy","year":"2007","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0085","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1439-0507.2007.01345.x","article-title":"Poor efficacy of amphotericin B-based therapy in CNS aspergillosis","volume":"50","author":"Schwartz","year":"2007","journal-title":"Mycoses"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0090","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0095","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1086\/377131","article-title":"Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients","volume":"37","author":"Lutsar","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0100","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2005-02-0733","article-title":"Improved outcome in central nervous system aspergillosis using voriconazole treatment","volume":"106","author":"Schwartz","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0105","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1128\/AAC.41.11.2339","article-title":"Preliminary animal pharmacokinetics of the parenteral antifungal agent MK-0991(L-743,872)","volume":"41","author":"Hajdu","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1086\/525258","article-title":"Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America","volume":"46","author":"Walsh","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.10.012_bib0115","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1086\/318483","article-title":"Aspergillosis case-fatality rate: systematic review of the literature","volume":"32","author":"Lin","year":"2001","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003695?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913003695?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,8]],"date-time":"2020-08-08T01:33:20Z","timestamp":1596850400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913003695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0924857913003695"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.10.012","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral aspergillosis in adult critically ill patients: a descriptive report of 10 patients from the AspICU cohort","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}